Open Label Extension (OLE) of the TDF2 Study, Botswana
Not Applicable
Completed
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2020-03-23
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 229
- Registration Number
- NCT04318210
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda
Not Applicable
Completed
- Conditions
- DiphtheriaPertussisPolioHaemophilus Influenzae Type b InfectionTetanusMeaslesHepatitis B
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2019-11-26
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 1962
- Registration Number
- NCT04177485
Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania
Not Applicable
Terminated
- Conditions
- MalariaMalaria in Pregnancy
- First Posted Date
- 2019-11-01
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 4515
- Registration Number
- NCT04148690
- Locations
- 🇹🇿
Chato District Hospital, Chato, Tanzania
Immunogenicity of Intramuscular and Intradermal IPV
Phase 4
Terminated
- Conditions
- Poliomyelitis
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 958
- Registration Number
- NCT04063150
- Locations
- 🇧🇩
icddr,b study clinics (Mirpur and CTU Dhaka), Dhaka, Bangladesh
Just-in-time Elastomeric Training and Fit Testing (JET FIT)
Not Applicable
Completed
- Conditions
- Infection
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 300
- Registration Number
- NCT03888898
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸Wayne State University, Detroit, Michigan, United States
🇺🇸University of Texas, Houston, Texas, United States
Tuberculosis Clinical Trials Consortium Study 35
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 72
- Registration Number
- NCT03730181
- Locations
- 🇿🇦
Desmond Tutu TB Center, University of Stellenbosch, Stellenbosch, South Africa
Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old
Phase 4
Completed
- Conditions
- Yellow Fever
- Interventions
- Biological: Yellow Fever 17DD Vaccine
- First Posted Date
- 2018-10-31
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 1788
- Registration Number
- NCT03725618
- Locations
- 🇺🇸
Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
Phase 4
Completed
- Conditions
- Influenza
- First Posted Date
- 2018-10-29
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 944
- Registration Number
- NCT03722589
- Locations
- 🇺🇸
Kaiser Permanente Northwest, Portland, Oregon, United States
🇺🇸Baylor Scott and White Health, Temple, Texas, United States
Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study
Phase 4
Completed
- Conditions
- Poliomyelitis
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 1256
- Registration Number
- NCT03722004
- Locations
- 🇧🇩
icddr,b study clinics (Mirpur and CTU Dhaka), Dhaka, Bangladesh
Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 257
- Registration Number
- NCT03610399
- Locations
- 🇧🇷
Hospital do Jurua, Cruzeiro do Sul, Brazil